Skip to main content Accessibility help

Risk of dementia associated with psychotic disorders in later life: the health in men study (HIMS)

  • Osvaldo P. Almeida (a1) (a2) (a3), Andrew H. Ford (a1) (a2) (a3), Graeme J. Hankey (a1) (a4), Bu B. Yeap (a1) (a5), Jonathan Golledge (a6) (a7) and Leon Flicker (a1) (a2) (a8)...



Recent research has identified several potentially modifiable risk factors for dementia, including mental disorders. Psychotic disorders, such as schizophrenia and delusional disorder, have also been associated with increased risk of cognitive impairment and dementia, but currently available data difficult to generalise because of bias and confounding. We designed the present study to investigate if the presence of a psychotic disorder increased the risk of incident dementia in later life.


Prospective cohort study of a community-representative sample of 37 770 men aged 65–85 years who were free of dementia at study entry. They were followed for up to 17.7 years using electronic health records. Clinical diagnoses followed the International Classification of Diseases guidelines. As psychotic disorders increase mortality, we considered death a competing risk.


A total of 8068 (21.4%) men developed dementia and 23 999 (63.5%) died during follow up. The sub-hazard ratio of dementia associated with a psychotic disorder was 2.67 (95% CI 2.30–3.09), after statistical adjustments for age and prevalent cardiovascular, respiratory, gastrointestinal and renal diseases, cancer, as well as hearing loss, depressive and bipolar disorders, and alcohol use disorder. The association between psychotic disorder and dementia risk varied slightly according to the duration of the psychotic disorder (highest for those with the shortest illness duration), but not the age of onset. No information about the use of antipsychotics was available.


Older men with a psychotic disorder have nearly three times greater risk of developing dementia than those without psychosis. The pathways linking psychotic disorders to dementia remain unclear but may involve mechanisms other than those associated with Alzheimer's disease and other common dementia syndromes.


Corresponding author

Author for correspondence: Professor Osvaldo P. Almeida, E-mail:


Hide All
Almeida, OP, Hankey, GJ, Yeap, BB, Golledge, J and Flicker, L (2017) Depression as a modifiable factor to decrease the risk of dementia. Translational Psychiatry 7, e1117.
Almeida, OP, Howard, RJ, Levy, R, David, AS, Morris, RG and Sahakian, BJ (1995) Clinical and cognitive diversity of psychotic states arising in late life (late paraphrenia). Psychological Medicine 25, 699714.
Almeida, OP, McCaul, K, Hankey, GJ, Yeap, BB, Golledge, J and Flicker, L (2016) Risk of dementia and death in community-dwelling older men with bipolar disorder. British Journal of Psychiatry 209, 121126.
Barnett, JH, Salmond, CH, Jones, PB and Sahakian, BJ (2006) Cognitive reserve in neuropsychiatry. Psychological Medicine 36, 10531064.
Breslow, NE, Lubin, JH, Marek, P and Langholz, B (1983) Multiplicative models and cohort analysis. Journal of the American Statistical Association 78, 112.
Brodaty, H, Sachdev, P, Koschera, A, Monk, D and Cullen, B (2003) Long-term outcome of late-onset schizophrenia: 5-year follow-up study. British Journal of Psychiatry 183, 213219.
Carr, VJ, Johnston, PJ, Lewin, TJ, Rajkumar, S, Carter, GL and Issakidis, C (2003) Patterns of service use among persons with schizophrenia and other psychotic disorders. Psychiatric Services 54, 226235.
Chen, YR, Swann, AC and Burt, DB (1996) Stability of diagnosis in schizophrenia. American Journal of Psychiatry 153, 682686.
Chung, JK, Nakajima, S, Plitman, E, Iwata, Y, Uy, D, Gerretsen, P et al. (2016) Beta-amyloid burden is not associated with cognitive impairment in achizophrenia: a systematic review. American Journal of Geriatric Psychiatry 24, 923939.
Copeland, JR, Dewey, ME, Scott, A, Gilmore, C, Larkin, BA, Cleave, N et al. (1998) Schizophrenia and delusional disorder in older age: community prevalence, incidence, comorbidity, and outcome. Schizophrenia Bulletin 24, 153161.
de Vries, PJ, Honer, WG, Kemp, PM and McKenna, PJ (2001) Dementia as a complication of schizophrenia. Journal of Neurology Neurosurgery and Psychiatry 70, 588596.
Fischer, CE and Aguera-Ortiz, L (2017) Psychosis and dementia: risk factor, prodrome, or cause? Internatinal Psychogeriatrics 30, 209219.
Harvey, PD, Silverman, JM, Mohs, RC, Parrella, M, White, L, Powchik, P et al. (1999) Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry 45, 3240.
Heinrichs, RW and Zakzanis, KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426445.
Ho, BC, Andreasen, NC, Ziebell, S, Pierson, R and Magnotta, V (2011) Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 68, 128137.
Holman, CD, Bass, AJ, Rosman, DL, Smith, MB, Semmens, JB, Glasson, EJ et al. (2008) A decade of data linkage in western Australia: strategic design, applications and benefits of the WA data linkage system. Australian Health Review 32, 766777.
Jablensky, AV, Morgan, V, Zubrick, SR, Bower, C and Yellachich, LA (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. American Journal of Psychiatry 162, 7991.
Jellinger, KA and Gabriel, E (1999) No increased incidence of Alzheimer's disease in elderly schizophrenics. Acta Neuropathologica 97, 165169.
Jones, P, Rodgers, B, Murray, R and Marmot, M (1994) Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 13981402.
Kahn, RS and Keefe, RS (2013) Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry 70, 11071112.
Kessing, LV, Gerds, TA, Knudsen, NN, Jorgensen, LF, Kristiansen, SM, Voutchkova, D et al. (2017) Association of lithium in drinking water With the incidence of dementia. JAMA Psychiatry 74, 10051010.
Kohler, S, Allardyce, J, Verhey, FR, McKeith, IG, Matthews, F, Brayne, C et al. (2013) Cognitive decline and dementia risk in older adults with psychotic symptoms: a prospective cohort study. American Journal of Geriatric Psychiatry 21, 119128.
Korner, A, Lopez, AG, Lauritzen, L, Andersen, PK and Kessing, LV (2008) Delusional disorder in old age and the risk of developing dementia: a nationwide register-based study. Aging and Mental Health 12, 625629.
Korner, A, Lopez, AG, Lauritzen, L, Andersen, PK and Kessing, LV (2009 a) Acute and transient psychosis in old age and the subsequent risk of dementia: a nationwide register-based study. Geriatrics and Gerontology International 9, 6268.
Korner, A, Lopez, AG, Lauritzen, L, Andersen, PK and Kessing, LV (2009 b) Late and very-late first-contact schizophrenia and the risk of dementia--a nationwide register based study. International Journal of Geriatric Psychiatry 24, 6167.
Lautenschlager, NT, Cox, KL, Flicker, L, Foster, JK, van Bockxmeer, FM, Xiao, J et al. (2008) Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. Journal of the American Medical Association 300, 10271037.
Livingston, G, Sommerlad, A, Orgeta, V, Costafreda, SG, Huntley, J, Ames, D et al. (2017) Dementia prevention, intervention, and care. Lancet 390, 26732734.
Moll van Charante, EP, Richard, E, Eurelings, LS, van Dalen, JW, Ligthart, SA, van Bussel, EF et al. (2016) Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet 388, 797805.
Morgan, VA, McGrath, JJ, Jablensky, A, Badcock, JC, Waterreus, A, Bush, R et al. (2014) Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychological Medicine 44, 21632176.
Ngandu, T, Lehtisalo, J, Solomon, A, Levalahti, E, Ahtiluoto, S, Antikainen, R et al. (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385, 22552263.
Norton, S, Matthews, FE, Barnes, DE, Yaffe, K and Brayne, C (2014) Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurology 13, 788794.
Purohit, DP, Perl, DP, Haroutunian, V, Powchik, P, Davidson, M and Davis, KL (1998) Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Archives of General Psychiatry 55, 205211.
Rabins, PV and Lavrisha, M (2003) Long-term follow-up and phenomenologic differences distinguish among late-onset schizophrenia, late-life depression, and progressive dementia. American Journal of Geriatric Psychiatry 11, 589594.
Rajji, TK, Miranda, D and Mulsant, BH (2014) Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies. Canadian Journal of Psychiatry 59, 1317.
Ribe, AR, Laursen, TM, Charles, M, Katon, W, Fenger-Gron, M, Davydow, D et al. (2015) Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study. JAMA Psychiatry 72, 10951101.
Soares, WB, Dos Santos, EB, Bottino, CMC and Elkis, H (2017) Psychotic symptoms in older people without dementia from a Brazilian community-based sample: a seven years’ follow-up. PLoS ONE 12, e0178471.
Szoke, A, Trandafir, A, Dupont, ME, Meary, A, Schurhoff, F and Leboyer, M (2008) Longitudinal studies of cognition in schizophrenia: meta-analysis. British Journal of Psychiatry 192, 248257.
Wisniewski, HM, Constantinidis, J, Wegiel, J, Bobinski, M and Tarnawski, M (1994) Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Disease and Associated Disorders 8, 211227.
Wu, YT, Beiser, AS, Breteler, MMB, Fratiglioni, L, Helmer, C, Hendrie, HC et al. (2017) The changing prevalence and incidence of dementia over time – current evidence. Nature Reviews Neurology 13, 327339.


Type Description Title
Supplementary materials

Almeida et al. supplementary material
Table S1

 Word (70 KB)
70 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed